Year archive

Torrent Pharmaceuticals Ltd. — 2024 filings

All 250 regulatory filings released by Torrent Pharmaceuticals Ltd. (TORNTPHARM) in 2024, sourced directly from the official regulator.

250 Filings

2024 Period

2024 filings (250)

Filing	Released	Lang
Trading Window Regulatory Filings	2024-12-27	English
Intimation of Closure of Trading Window Regulatory Filings	2024-12-27	English
Issue of Securities Regulatory Filings	2024-12-26	English
Intimation regarding Issue of Commercial Papers. Regulatory Filings	2024-12-26	English
Updates Regulatory Filings	2024-12-19	English
Redemption of Commercial Papers Regulatory Filings	2024-12-19	English
Partial Redemption of NCDs Regulatory Filings	2024-12-13	English
Copy of Newspaper Publication Regulatory Filings	2024-12-09	English
Newspaper Publication with respect to IEPF. Regulatory Filings	2024-12-09	English
Press Release Regulatory Filings	2024-12-04	English
Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands Regulatory Filings	2024-12-04	English
Announcement under reg 30 Regulatory Filings	2024-11-28	English
Action(s) initiated or orders passed Regulatory Filings	2024-11-28	English
Intimation of Loss of Share certificates Regulatory Filings	2024-11-27	English
Loss of Share Certificates Regulatory Filings	2024-11-27	English
Loss of Share Certificates Regulatory Filings	2024-11-27	English
Intimation of Issue of Duplicate Share Certificates Regulatory Filings	2024-11-27	English
General Updates Regulatory Filings	2024-11-22	English
Intimation under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-11-22	English
Earning Call Transcript Regulatory Filings	2024-10-30	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-10-30	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Torrent Investments Pvt Ltd Regulatory Filings	2024-10-30	English
Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2024. Regulatory Filings	2024-10-25	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-10-25	English
Investor Presentation on Financial Results Q2 FY 2024-25. Regulatory Filings	2024-10-25	English
Investor Presentation Regulatory Filings	2024-10-25	English
Press Release Regulatory Filings	2024-10-25	English
Outcome of Board Meeting Dated 25-10-2024 Regulatory Filings	2024-10-25	English
Outcome of Board Meeting Regulatory Filings	2024-10-25	English
Results Q2 FY 2024-25. Regulatory Filings	2024-10-25	English
Financial Result Updates Regulatory Filings	2024-10-25	English
Intimation of Credit Rating Regulatory Filings	2024-10-24	English
Credit Rating Regulatory Filings	2024-10-24	English
Loss of Share Certificates Regulatory Filings	2024-10-24	English
Intimation of Loss of Share Certificates Regulatory Filings	2024-10-24	English
Loss of Share Certificates Regulatory Filings	2024-10-21	English
Intimation of Loss of Share Certificates Regulatory Filings	2024-10-21	English
General Updates Regulatory Filings	2024-10-18	English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-10-18	English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-10-15	English
General Updates Regulatory Filings	2024-10-15	English
Post Quarterly Financial Result Conference call with investors / analyst Regulatory Filings	2024-10-14	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-10-14	English
Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 25-Oct-2024 to consider and approve the Quarterly Unaudited Financial results of the Compan… Regulatory Filings	2024-10-10	English
Board Meeting — Financial Results/Other business matters Regulatory Filings	2024-10-10	English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 ,inter alia, to consider and approve the Audited Financial .... Regulatory Filings	2024-10-10	English
Trading Window Regulatory Filings	2024-09-27	English
Intimation of Closure of Trading Window Regulatory Filings	2024-09-27	English
Updates Regulatory Filings	2024-09-26	English
Intimation for Incorporation of Wholly Owned Subsidiary (WOS) Regulatory Filings	2024-09-26	English
Press Release Regulatory Filings	2024-09-26	English
Press Release Attached. Regulatory Filings	2024-09-26	English
Intimation of issue of duplicate share certificates Regulatory Filings	2024-09-25	English
Loss of Share Certificates Regulatory Filings	2024-09-25	English
Intimation of Schedule of Investors Meets under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-09-24	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-09-24	English
Loss of Share Certificates Regulatory Filings	2024-09-24	English
Intimation of Loss of Share Certificates Regulatory Filings	2024-09-24	English
Issue of Securities Regulatory Filings	2024-09-20	English
Intimation regarding Issue of Commercial Papers Regulatory Filings	2024-09-20	English
Updates Regulatory Filings	2024-09-20	English
PFA Regulatory Filings	2024-09-20	English
Updates Regulatory Filings	2024-09-02	English
Disclosure under regulation 30 of SEBI Listing Regulations Regulatory Filings	2024-09-02	English
Loss of Share Certificates Regulatory Filings	2024-08-30	English
Intimation of Loss of Share Certificate Regulatory Filings	2024-08-30	English
Loss of Share Certificates Regulatory Filings	2024-08-30	English
Intimation of Issue of Duplicate Share Certificates Regulatory Filings	2024-08-30	English
Updates Regulatory Filings	2024-08-30	English
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-08-30	English
Updates Regulatory Filings	2024-08-29	English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-08-29	English
Updates Regulatory Filings	2024-08-28	English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-08-28	English
Updates Regulatory Filings	2024-08-27	English
Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-08-27	English
Credit Rating Regulatory Filings	2024-08-23	English
Intimation of Credit Rating Regulatory Filings	2024-08-23	English
News Verification Regulatory Filings	2024-08-14	English
Clarification / Information on news item Regulatory Filings	2024-08-14	English
Change in Management Regulatory Filings	2024-08-13	English
Change in Senior Management Personnel Regulatory Filings	2024-08-13	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-07-29	English
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024 Regulatory Filings	2024-07-29	English
Shareholders meeting Regulatory Filings	2024-07-24	English
Declaration of Voting Results Regulatory Filings	2024-07-24	English
Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024 Regulatory Filings	2024-07-23	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-07-23	English
Change in Senior Management Personnel. Regulatory Filings	2024-07-23	English
Cessation Regulatory Filings	2024-07-23	English
Change in Management Regulatory Filings	2024-07-23	English
Intimation of Cessation. Regulatory Filings	2024-07-23	English
Proceeding of 51st AGM held on 23-07-2024. Regulatory Filings	2024-07-23	English
Shareholders meeting Regulatory Filings	2024-07-23	English
Investor Presentation. Regulatory Filings	2024-07-23	English
Outcome of Board Meeting Dated 23-07-2024. Regulatory Filings	2024-07-23	English
Investor Presentation Regulatory Filings	2024-07-23	English
Outcome of Board Meeting Regulatory Filings	2024-07-23	English
Results Q1 FY 2024-25. Regulatory Filings	2024-07-23	English
Financial Result Updates Regulatory Filings	2024-07-23	English
Post Quarterly Financial Result Conference call with investors / analyst Regulatory Filings	2024-07-18	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-07-18	English
Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Jul-2024 to consider and approve the Quarterly Unaudited Financial results of the Compan… Regulatory Filings	2024-07-05	English
Board Meeting — Financial Results/Other business matters Regulatory Filings	2024-07-05	English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 ,inter alia, to consider and approve We would like to inform .... Regulatory Filings	2024-07-05	English
Loss of Share Certificates Regulatory Filings	2024-07-03	English
Intimation of Loss of Share Certificates Regulatory Filings	2024-07-03	English
Copy of Newspaper Publication Regulatory Filings	2024-07-01	English
Newspaper cuttings in connection with the 51st Annual General Meeting and E-Voting Procedure. Regulatory Filings	2024-07-01	English
Updates Regulatory Filings	2024-06-29	English
Shareholders meeting Regulatory Filings	2024-06-29	English
Submission of the Annual Report for the FY 2023-24 and the Notice convening 51st AGM of the Company Regulatory Filings	2024-06-29	English
Submission of the Business Responsibility and Sustainability Report (BRSR) for FY 2023-24 of the Company Regulatory Filings	2024-06-29	English
Submission of Annual Report for FY 2023-24 and intimation of voting through electronic means Regulatory Filings	2024-06-29	English
Intimation of the Closure of Trading Window as per Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons Regulatory Filings	2024-06-28	English
Trading Window Regulatory Filings	2024-06-28	English
Newspaper Advertisement - Intimation of the 51st Annual General Meeting of the Company through Video Conferencing / Other Audio Visual Means ("VC / OAVM") facility Regulatory Filings	2024-06-25	English
Copy of Newspaper Publication Regulatory Filings	2024-06-25	English
Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-06-21	English
Updates Regulatory Filings	2024-06-21	English
Intimation of Loss of Share Certificates Regulatory Filings	2024-06-19	English
Loss of Share Certificates Regulatory Filings	2024-06-19	English
Intimation of loss of share certificate Regulatory Filings	2024-06-13	English
Loss of Share Certificates Regulatory Filings	2024-06-13	English
Updates Regulatory Filings	2024-06-12	English
Intimation under regulation 30 of SEBI (LODR) regulation, 2015 Regulatory Filings	2024-06-12	English
Press Release Regulatory Filings	2024-06-05	English
Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India Regulatory Filings	2024-06-05	English
Transcript of Conference Call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2024 Regulatory Filings	2024-05-30	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-05-30	English
Copy of Newspaper Publication Regulatory Filings	2024-05-29	English
Copies of Newspaper cuttings in connection with transfer of shares to IEPF. Regulatory Filings	2024-05-29	English
Resignation Regulatory Filings	2024-05-24	English
In continuation to our earlier letter dated 24-May-24 intimating the desire of Jinesh Shah to step down as the Director of the Company effective from 23-Jul-24, please find the letter attached .... Regulatory Filings	2024-05-24	English
In continuation to our letter dated 10-May-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference .... Regulatory Filings	2024-05-24	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-05-24	English
Date of payment of dividend Regulatory Filings	2024-05-24	English
Dividend Updates Regulatory Filings	2024-05-24	English
Date of payment of final dividend for the year 2023-24 Regulatory Filings	2024-05-24	English
Dividend updates Regulatory Filings	2024-05-24	English
Record Date Regulatory Filings	2024-05-24	English
Record date intimation for Final Dividend for the year 2023-24 Regulatory Filings	2024-05-24	English
Raising of funds Regulatory Filings	2024-05-24	English
Raising of funds Regulatory Filings	2024-05-24	English
Change in Directorate Regulatory Filings	2024-05-24	English
Dividend Updates Regulatory Filings	2024-05-24	English
Investor presentation Regulatory Filings	2024-05-24	English
Investor Presentation Regulatory Filings	2024-05-24	English
Outcome of Board meeting dated 24-May-24 Regulatory Filings	2024-05-24	English
Dividend Regulatory Filings	2024-05-24	English
Change in Director(s) Regulatory Filings	2024-05-24	English
Outcome of Board Meeting Regulatory Filings	2024-05-24	English
Results Regulatory Filings	2024-05-24	English
Financial Result Updates Regulatory Filings	2024-05-24	English
Loss of Share Certificates Regulatory Filings	2024-05-21	English
Intimation of Loss of share certificate Regulatory Filings	2024-05-21	English
Annual Secretarial Compliance Report for the year ended 31-Mar-24 Regulatory Filings	2024-05-16	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-05-10	English
Post Quarterly Financial Result Conference call with investors / analyst Regulatory Filings	2024-05-10	English
Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2024 to consider and approve the Yearly Audited Financial results of the Company for… Regulatory Filings	2024-05-10	English
Board Meeting — Financial Results/Dividend/Fund Raising Regulatory Filings	2024-05-10	English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 ,inter alia, to consider and approve We would like to inform .... Regulatory Filings	2024-05-10	English
Intimation of Issue of Duplicate Share Certificates Regulatory Filings	2024-05-09	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2024-05-03	English
Intimation of Loss of Share Certificate Regulatory Filings	2024-05-02	English
Updates Regulatory Filings	2024-05-02	English
Updates Regulatory Filings	2024-05-02	English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-05-02	English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-30	English
Updates Regulatory Filings	2024-04-30	English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-04-23	English
Updates Regulatory Filings	2024-04-23	English
Updates Regulatory Filings	2024-04-19	English
Disclosure under Regulation 30 of SEBI (Listing Obligation and disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-19	English
Compliance Certificate u/r 40(9) of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-04-12	English
Conclusion time of the 50th Annual General Meeting of the Company Regulatory Filings	2024-04-09	English
Disclosure u/r 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-08	English
Updates Regulatory Filings	2024-04-08	English
Compliance Certificate under Regulation 7(3) Regulatory Filings	2024-04-04	English
Intimation of Cessation of Directors of the Company Regulatory Filings	2024-04-01	English
Intimation of Cessation of Directors of Company Regulatory Filings	2024-04-01	English
Intimation of Cessation of Directors of the Company Regulatory Filings	2024-04-01	English
Change in Director(s) Regulatory Filings	2024-04-01	English
Retirement Regulatory Filings	2024-04-01	English
Intimation of the Closure of Trading Window Regulatory Filings	2024-03-27	English
Trading Window Regulatory Filings	2024-03-27	English
Intimation of loss of share certificates Regulatory Filings	2024-03-13	English
Loss of Share Certificates Regulatory Filings	2024-03-13	English
Intimation u/r 30 of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-03-05	English
Updates Regulatory Filings	2024-03-05	English
Intimation of Loss of Share Certificate Regulatory Filings	2024-03-05	English
Loss of Share Certificates Regulatory Filings	2024-03-05	English
Intimation of Issue of Duplicate Share Certificates Regulatory Filings	2024-03-01	English
Loss of Share Certificates Regulatory Filings	2024-03-01	English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-01	English
Updates Regulatory Filings	2024-03-01	English
Change in Senior Management Personnel Regulatory Filings	2024-02-29	English
Change in Management Regulatory Filings	2024-02-29	English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-16	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-02-16	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-02-12	English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-12	English
Intimation of Issue of Duplicate Share Certificates Regulatory Filings	2024-02-07	English
Loss of Share Certificates Regulatory Filings	2024-02-07	English
Loss of Share Certificates Regulatory Filings	2024-02-07	English
Intimation of Loss of Share Certificates Regulatory Filings	2024-02-07	English
Transcript of Conference Call with Analysts / Investor on Financial Results for the quarter and nine months ended 31st December, 2023 Regulatory Filings	2024-02-07	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-02-07	English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-06	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-02-06	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-02-03	English
Intimation of Schedule of Investors Meets under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-03	English
Audio recording Regulatory Filings	2024-02-02	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-02-02	English
Date of payment of dividend Regulatory Filings	2024-02-02	English
Dividend update Regulatory Filings	2024-02-02	English
Press Release Regulatory Filings	2024-02-02	English
Date of payment of dividend Regulatory Filings	2024-02-02	English
Dividend Updates Regulatory Filings	2024-02-02	English
Dividend update Regulatory Filings	2024-02-02	English
Investor presentation Regulatory Filings	2024-02-02	English
Investor Presentation Regulatory Filings	2024-02-02	English
BM outcome Regulatory Filings	2024-02-02	English
Outcome of Board Meeting Regulatory Filings	2024-02-02	English
Dividend Regulatory Filings	2024-02-02	English
Financial Result Updates Regulatory Filings	2024-02-02	English
Result Regulatory Filings	2024-02-02	English
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-30	English
Updates Regulatory Filings	2024-01-30	English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs Regulatory Filings	2024-01-30	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust 1 & Others & PACs Regulatory Filings	2024-01-30	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs Regulatory Filings	2024-01-24	English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mehta Family Trust & PACs Regulatory Filings	2024-01-24	English
Post Quarterly Financial Result Conference call with investors / analyst Regulatory Filings	2024-01-22	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-01-22	English
Updates Regulatory Filings	2024-01-20	English
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-20	English
Updates Regulatory Filings	2024-01-13	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-13	English
Intimation of Record Date pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-12	English
Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Compan… Regulatory Filings	2024-01-12	English
Board Meeting — Financial Results/Dividend/Other business matters Regulatory Filings	2024-01-12	English
Record Date Regulatory Filings	2024-01-12	English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 ,inter alia, to consider and approve We would like to inform .... Regulatory Filings	2024-01-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-01-09	English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-09	English
Acquisition Regulatory Filings	2024-01-04	English
Intimation of Incorporation of wholly owned subsidiary Regulatory Filings	2024-01-04	English
Loss of Share Certificates Regulatory Filings	2024-01-02	English
Intimation of Loss of Share Certificates Regulatory Filings	2024-01-02	English

Filings by year

2026 107 filings
2025 209 filings
2024 250 filings
2023 208 filings
2022 205 filings
2021 189 filings
2020 174 filings
2019 174 filings
2018 52 filings
2017 51 filings
2016 45 filings
2015 41 filings
2014 20 filings
2013 16 filings
2012 4 filings
2011 4 filings
2010 1 filing